Durham, NC, United States of America

Marcus F Brackeen


Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 1991-1995

Loading Chart...
6 patents (USPTO):

Title: The Innovative Mind of Marcus F. Brackeen

Introduction

Marcus F. Brackeen, a distinguished inventor based in Durham, North Carolina, has made significant contributions to the field of pharmaceutical chemistry. With a total of six patents to his name, his work largely centers around the development of analgesic compounds that hold promise for effective pain management.

Latest Patents

Marcus's latest patents delve into the creation of intermediates for synthesizing analgesic N-phenyl-N-(3-OR) compounds. These novel piperidinyl intermediates play a vital role in the formulation of N-phenyl-N-(4-piperidinyl) amides, which exhibit potent analgesic activity. His inventions include a range of derivatives characterized by specific structures and functionalities, showcasing their potential therapeutic applications. The patents describe pharmaceutical compositions and methods utilizing these compounds to provide analgesic effects, thus paving the way for new treatment avenues.

Career Highlights

Currently affiliated with Glaxo Inc., Marcus Brackeen continues to be at the forefront of pharmaceutical innovation. His dedication to research and development has not only led to the filing of valuable patents but has also advanced the understanding of analgesic mechanisms. His ongoing work is vital to the future of pain relief medications.

Collaborations

Throughout his career, Brackeen has collaborated with notable coworkers such as Paul L. Feldman and Michael K. James. These partnerships have fostered a collaborative spirit that enhances the innovation process, allowing for a sharing of ideas and expertise, which is critical in the highly competitive pharmaceutical industry.

Conclusion

Marcus F. Brackeen exemplifies the traits of a modern inventor, combining knowledge, creativity, and collaboration to push the boundaries of what is possible in pain management. His valuable patents not only contribute to the scientific community but also hold the potential to improve the quality of life for countless patients suffering from pain. As he continues to work at Glaxo Inc., the future of pharmaceutical advancements looks promising under his guidance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…